The importance of PP2B/NFAT signaling in cardiac hypertrophy was first recognized in 1998, when Molkentin et al. (1998) demonstrated that overexpression of activated PP2B of NFATc4 lead to cardiac hypertrophy. The gene discussed is NFATC4; the disease is cardiac hypertrophy.